Advances and Outlooks for Immunotherapy of Cancer
- 1 October 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Hybridoma
- Vol. 12 (5) , 493-500
- https://doi.org/10.1089/hyb.1993.12.493
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factorCancer Immunology, Immunotherapy, 1992
- Recombinant Toxins for Cancer TreatmentScience, 1991
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2Immunology Letters, 1990
- Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon γCancer Immunology, Immunotherapy, 1990
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Human Macrophages Armed with Murine Immunoglobulin G2a Antibodies to Tumors Destroy Human Cancer CellsScience, 1983
- Hypothesis: Macrophages as Effector Cells For Human Tumor Destruction Mediated by Monoclonal AntibodyHybridoma, 1983
- Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with CarcinomaNew England Journal of Medicine, 1980
- Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinomaEuropean Journal of Immunology, 1979